China Pharma Holdings (CPHI) EBITDA Margin Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | -10,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,332.00 |
| Dec 31, 2025 | -5,787.00 |
| Sep 30, 2025 | -4,803.00 |
| Jun 30, 2025 | -1,525.00 |
| Mar 31, 2025 | -992.00 |
| Dec 31, 2024 | -8,302.00 |
| Sep 30, 2024 | -6,011.00 |
| Jun 30, 2024 | -11,927.00 |
| Mar 31, 2024 | -3,734.00 |
| Dec 31, 2023 | -1,752.00 |
| Sep 30, 2023 | 11.00 |
| Jun 30, 2023 | -4,355.00 |
| Mar 31, 2023 | 1,370.00 |
| Dec 31, 2022 | 57,261.00 |
| Sep 30, 2022 | -788.00 |
| Jun 30, 2022 | -1,902.00 |
| Mar 31, 2022 | -4,543.00 |
| Dec 31, 2021 | 20,917.00 |
| Sep 30, 2021 | 4,550.00 |
| Jun 30, 2021 | -393.00 |